4327.0: Tuesday, October 23, 2001: 8:30 PM-10:00 PM | ||||
Oral Session | ||||
| ||||
| See individual abstracts for presenting author's disclosure statement. | ||||
| Learning Objectives: See individual abstracts | ||||
| Kathy Magruder, DrPH | ||||
| Employee drug use and the effects of workplace drug testing programs Michael T. French, PhD, M. Christopher Roebuck, MBA, Pierre Alexandre | ||||
| Effects of drug testing and prevention education strategies on health care costs and attitudes in the workplace David L. Blank, PhD, J. Michael Walsh, PhD, Leo Cangianelli | ||||
| Enhancing inferences about workplace substance abuse programs William Schlenger, PhD, Jeremy Bray, Georgia Karuntzos, MSIR, Deborah Galvin | ||||
| Findings from the cross site analysis of the workplace managed care initiative William Schlenger, PhD, Jeremy Bray, PhD, Georgia Karuntzos, MSIR, Deborah Galvin | ||||
| Workplace substance abuse programs: Factors in adoption Paul Steele, PhD, William Schlenger, PhD, Tyler Hartwell, PhD | ||||
| Sponsor: | Alcohol, Tobacco, and Other Drugs | |||
| Cosponsors: | Occupational Health and Safety | |||
| CE Credits: | CME, Health Education (CHES), Nursing, Pharmacy, Social Work | |||